Grayslake, IL, United States of America

Russell Drew Cink

USPTO Granted Patents = 17 

 


Average Co-Inventor Count = 9.9

ph-index = 5

Forward Citations = 206(Granted Patents)


Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Russell Drew Cink

Introduction

Russell Drew Cink, a notable inventor residing in Grayslake, IL, has made significant contributions to the field of chemistry through his innovative approach to synthesizing complex chemical compounds. With a total of 17 patents to his name, Cink's work primarily focuses on the development of methods for creating important chemical intermediates that can aid in pharmaceutical applications.

Latest Patents

Cink's latest patents showcase his expertise in enzymatic processes. His recent inventions include methods for synthesizing racemic 2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acids and 2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acids, as well as their respective salts. Additionally, he has developed methods for the preparation of enantioenriched (1R,2R)-1-((tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropane-1-carboxylic acid and its esters. These compounds serve as crucial intermediates in the synthesis of viral protease inhibitors, fostering advancements in antiviral drug development. Cink's inventive techniques enable the production of viral protease inhibitors in high yield while avoiding the pitfalls of expensive catalysts and difficult reaction conditions.

Career Highlights

Throughout his career, Russell Drew Cink has worked with esteemed pharmaceutical companies, including AbbVie Inc. and Abbott Laboratories Corporation. His roles in these organizations have allowed him to leverage his inventive skills and focus on the synthesis of valuable chemical compounds that address critical healthcare challenges.

Collaborations

Cink has collaborated with prominent scientists in the field, including Marvin Robert Leanna and Richard D. Bishop. These partnerships have facilitated the exchange of ideas and have further enhanced the development of innovative solutions within the pharmaceutical industry.

Conclusion

Russell Drew Cink's extensive portfolio of patents and his unwavering commitment to chemical innovation underscore his important role in advancing pharmaceutical science. His contributions not only reflect his individual creativity and expertise but also highlight the collaborative nature of scientific exploration that drives progress in drug development and healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…